High Pin1 expression is associated with tumor progression in colorectal cancer

Journal of Surgical Oncology

Volumn 94, Issue 2, 2006, Pages 155-160

  Kuramochi, Junichi ^a   Arai, Takehiro ^a   Ikeda, Satoshi ^a   Kumagai, Jiro ^a   Uetake, Hiroyuki ^a   Sugihara, Kenichi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

catenin; Colorectal cancer; Cyclin D1; Pin1

Indexed keywords

ANTIBODY; BETA CATENIN; CYCLIN D1; CYCLOPHILIN; PEPTIDYLPROLYL ISOMERASE;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL FEATURE; COLON CARCINOGENESIS; COLORECTAL CANCER; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR GROWTH; CANCER INVASION; COLORECTAL TUMOR; DISEASE COURSE; ENZYMOLOGY; GENE EXPRESSION REGULATION; LYMPH NODE METASTASIS; METABOLISM; MORTALITY; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SURVIVAL RATE;

AGED; BETA CATENIN; COLORECTAL NEOPLASMS; CYCLIN D1; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; NEOPLASM INVASIVENESS; PEPTIDYLPROLYL ISOMERASE; SIGNAL TRANSDUCTION; SURVIVAL RATE;

EID: 33747127543     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20510     Document Type: Article

References (36)

1. Bienz M, Clevers H: Linking colorectal cancer to Wnt signaling. Cell 2000;103:311-320.
2. Kobayashi M, Honma T, Matsuda Y, et al.: Nuclear translocation of beta-catenin in colorectal cancer. Br J Cancer 2000;82:1689-1693.
3. Tetsu O, McCormick F: Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999;398:422-426.
4. Shtutman M, Zhurinsky J, Simcha I, et al.: The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 1999;96:5522-5527.
5. Arber N, Hibshoosh H, Moss SF, et al.: Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology 1996;110:669-674.
6. Palmqvist R, Stenling R, Oberg A, et al.: Expression of cyclin D1 and retinoblastonia protein in colorectal cancer. Eur J Cancer 1998;34:1575-1581.
7. Maeda K, Chung Y, Kang S, et al.: Cyclin D1 overexpression and prognosis in colorectal adenocarcinoma. Oncology 1998;55:145-151.
8. Rowan AJ, Lamlum H, Ilyas M, et al.: APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits". Proc Natl Acad Sci USA 2000;97:3352-3357.
9. Goss KH, Groden J: Biology of the adenomatous polyposis coli tumor suppressor. J Clin Oncol 2000;18:1967-1979.
10. Molenaar M, van de Wetering M, Oosterwegel M, et al.: XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell 1996;86:391-399.
11. Behrens J, von Kries JP, Kuhl M, et al.: Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 1996;382:638-642.
12. Huber O, Korn R, McLaughlin J, et al.: Nuclear localization of beta-catenin by interaction with transcription factor LEF-1. Mech Dev 1996;59:3-10.
13. Miller JR, Hocking AM, Brown JD, et al.: Mechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca2+ pathways. Oncogene 1999;18:7860-7872.
14. Chen RH, Ding WV, McCormick F: Wnt signaling to beta-catenin involves two interactive components. Glycogen synthase kinase-3beta inhibition and activation of protein kinase C. J Biol Chem 2000;275:17894-17899.
15. He TC, Sparks AB, Rago C, et al.: Identification of c-MYC as a target of the APC pathway. Science 1998;281:1509-1512.
16. Ryo A, Liou YC, Lu KP, et al.: Prolyl isomerase Pin1: A catalyst for oncogenesis and a potential therapeutic target in cancer. J Cell Sci 2003;116:773-783.
17. Blume-Jensen P, Hunter T: Oncogenic kinase signalling. Nature 2001;411:355-365.
18. Lu KP, Liou YC, Zhou XZ: Pinning down proline-directed phosphorylation signaling. Trends Cell Biol 2002;12:164-172.
19. Yaffe MB, Schutkowski M, Shen M, et al.: Sequence-specific and phosphorylation-dependent proline isomerization: A potential mitotic regulatory mechanism. Science 1997;278:1957-1960.
20. Ranganathan R, Lu KP, Hunter T, et al.: Structural and functional analysis of the mitotic rotamase Pin1 suggests substrate recognition is phosphorylation dependent. Cell 1997;89:875-886.
21. Lu KP, Hanes SD, Hunter T: A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 1996;380:544-547.
22. Lu KP: Prolyl isomerase Pin1 as a molecular target for cancer diagnostics and therapeutics. Cancer Cell 2003;4:175-180.
23. Ryo A, Nakamura M, Wulf G, et al.: Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC. Nat Cell Biol 2001;3:793-801.
24. Liou YC, Ryo A, Huang HK, et al.: Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes. Proc Natl Acad Sci USA 2002;99:1335-1340.
25. Pang R, Yuen J, Yuen MF, et al.: PIN1 overexpression and beta-catenin gene mutations are distinct oncogenic events in human hepatocellular carcinoma. Oncogene 2004;29:200-209.
26. Bao L, Kimzey A, Sauter G, et al.: Prevalent overexpression of prolyl isomerase Pin1 in human cancers. Am J Pathol 2004;164:1727-1737.
27. Ayala G, Wang D, Wulf G, et al.: The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer. Cancer Res 2003;63:6244-6251.
28. Nakashima M, Meirmanov S, Naruke Y, et al.: Cyclin D1 overexpression in thyroid tumours from a radio-contaminated area and its correlation with Pin1 and aberrant beta-catenin expression. J Pathol 2004;202:446-455.
29. Miyashita H, Mori S, Motegi K, et al.: Pin1 is overexpressed in oral squamous cell carcinoma and its levels correlate with cyclin D1 overexpression. Oncol Rep 2003;10:455-461.
30. Wulf GM, Ryo A, Wulf GG, et al.: Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. EMBO J 2001;20:3459-3472.
31. Frederick LG, David LP, Irvin DF, et al., editors: AJCC cancer staging manual. New York: Springer-Verlag; 2002.
32. Holland TA, Elder J, McCloud JM, et al.: Subcellular localisation of cyclin D1 protein in colorectal tumours is associated with p21(WAF1/CIP1) expression and correlates with patient survival. Int J Cancer 2001;95:302-306.
33. Samowitz WS, Powers MD, Spirio LN, et al.: Beta-catenin mutations are more frequent in small colorectal adenomas than in larger adenomas and invasive carcinomas. Cancer Res 1999;59:1442-1444.
34. Kinzler KW. Vogelstein B: Lessons from hereditary colorectal cancer. Cell 1996;87:159-170.
35. Wong SC, Lo ES, Lee KC, et al.: Prognostic and diagnostic significance of beta-catenin nuclear immunostaining in colorectal cancer. Clin Cancer Res 2004;10:1401-1408.
36. Utsunomiya T, Doki Y, Takemoto H, et al.: Correlation of beta-catenin and cyclin D1 expression in colon cancers. Oncology 2001;61:226-233.